• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Japan

MA
Pharma

Alfasigma gains drug, new territories with M&A play

Through the deal, Alfasigma will add key drugs like Nordimet, a methotrexate injection, to its rheumatology portfolio.
Donavyn Coffey Aug 12, 2026 11:23am
Two businessmen pushing giant puzzle pieces together as the sun sets behind them

Tanabe to sell manufacturing unit, rights to 17 meds to Towa

Jul 7, 2026 8:54am
Xocova COVID-19

Shionogi's Japan-approved antiviral nets US COVID nod

Jun 1, 2026 11:11am
china chinese Asia

More biotech hawkishness, Pfizer’s $10B deal—Fierce Pharma Asia

May 29, 2026 8:30am
Japanese flag

Global pharma leaders convene in Japan

May 28, 2026 11:37am
Japan Japan pharma Japanese pharma Japan biopharma

Tavneos patient starts resume in Japan amid safety scrutiny

May 21, 2026 11:38am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings